Acetilsalicilatna kiselina G.L. Pharma 100 mg tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

acetilsalicilatna kiselina g.l. pharma 100 mg tablete

g.l. pharma gmbh, schlossplatz 1, lannach, austrija - acetilsalicilatna kiselina - tableta - 100 mg - urbroj: jedna tableta sadrži 100 mg acetilsalicilatne kiseline

Trandolapril PharmaS 0,5 mg tvrde kapsule Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

trandolapril pharmas 0,5 mg tvrde kapsule

pharmas d.o.o., radnička cesta 47, zagreb, hrvatska - trandolapril - kapsula, tvrda - urbroj: 1 kapsula sadrži 0,50 mg trandolaprila

Trandolapril PharmaS 2 mg tvrde kapsule Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

trandolapril pharmas 2 mg tvrde kapsule

pharmas d.o.o., radnička cesta 47, zagreb, hrvatska - trandolapril - kapsula, tvrda - urbroj: 1 kapsula sadrži 2 mg trandolaprila

Trandolapril PharmaS 4 mg tvrde kapsule Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

trandolapril pharmas 4 mg tvrde kapsule

pharmas d.o.o., radnička cesta 47, zagreb, hrvatska - trandolapril - kapsula, tvrda - urbroj: 1 kapsula sadrži 4 mg trandolaprila

Trandolapril PharmaS 0,5 mg kapsule Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

trandolapril pharmas 0,5 mg kapsule

pharmas d.o.o., radnička cesta 47, zagreb, hrvatska - trandolapril - kapsula, tvrda - 0,5 mg - urbroj: jedna kapsula sadrži 0,5 mg trandolaprila

Trandolapril PharmaS 2 mg kapsule Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

trandolapril pharmas 2 mg kapsule

pharmas d.o.o., radnička cesta 47, zagreb, hrvatska - trandolapril - kapsula, tvrda - 2 mg - urbroj: jedna kapsula sadrži 2 mg trandolaprila

Trandolapril PharmaS 4 mg kapsule Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

trandolapril pharmas 4 mg kapsule

pharmas d.o.o., radnička cesta 47, zagreb, hrvatska - trandolapril - kapsula, tvrda - 4 mg - urbroj: jedna kapsula sadrži 4 mg trandolaprila

TRANDOLAPRIL PharmaS 0.5 mg/1 kapsula kapsula, tvrda Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

trandolapril pharmas 0.5 mg/1 kapsula kapsula, tvrda

pharmas d.o.o. sarajevo - trandolapril - kapsula, tvrda - 0.5 mg/1 kapsula - 1 kapsula, tvrda sadrži: 0,5 mg trandolapril

TRANDOLAPRIL PharmaS 2 mg/1 kapsula kapsula, tvrda Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

trandolapril pharmas 2 mg/1 kapsula kapsula, tvrda

pharmas d.o.o. sarajevo - trandolapril - kapsula, tvrda - 2 mg/1 kapsula - 1 kapsula, tvrda sadrži: 2 mg trandolapril

Clopidogrel Taw Pharma (previously Clopidogrel Mylan) Europska Unija - hrvatski - EMA (European Medicines Agency)

clopidogrel taw pharma (previously clopidogrel mylan)

taw pharma (ireland) limited - klopidogrel hidroklorid - peripheral vascular diseases; stroke; myocardial infarction; acute coronary syndrome - antitrombotska sredstva - , , , , secondary prevention of atherothrombotic events, , clopidogrel is indicated in: , - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. , - adult patients suffering from acute coronary syndrome:,    - non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). ,     - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy. , , in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is), clopidogrel in combination with asa is indicated in:, - adult patients with moderate to high-risk tia (abcd2  score ≥4) or minor is (nihss  ≤3) within 24 hours of either the tia or is event.  , , prevention of atherothrombotic and thromboembolic events in atrial fibrillation, in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. , , for further information please refer to section 5. , , ,.